Latest News & Features
Americas
The US Patent Trial and Appeal Board has given the go-ahead for an inter partes review of a Chinese pharma company’s US patent related to a treatment for Alzheimer’s. 22 July 2021
Generics
In the second of a four-part series, Sophie Topham of Marks & Clerk explains the rules around the exemption for studies, tests, and trials required for generic and biosimilar medicines. 22 July 2021
Medtech
A Cannabis industry event company has filed a counterclaim suit to invalidate trademarks held by a competitor, who has accused them of unfair competition. 20 July 2021
Big Pharma
The Patent Trial and Appeal Board has ruled that a Medytox patent for its wrinkle treatment should not have been granted. 20 July 2021
Plant Varieties
A Nevada federal court judge has overruled objections to a previous ruling on a dispute between investors and cannabidiol company CV Sciences. 20 July 2021
Americas
Barnes & Thornburg has added three new life science IP lawyers to the firm’s new Boston office. 16 July 2021
article
The emerging digital health industry is relatively novel, but its benefits are becoming more evident. Case investment and regulatory activity are becoming more apparent, as is the need for IP protection in the field. 15 July 2021
Europe
The UK’s Competition and Markets Authority has imposed fines of £260 million on drug companies for raising the price of life-saving hydrocortisone tablets by 10,000%. 15 July 2021
Americas
Novartis should pay a Daiichi Sankyo subsidiary, Plexxikon, $47 million in overdue IP royalties, according to an argument presented before a federal court in California this week. 15 July 2021
Big Pharma
In the first of a four-part series, Sophie Topham of Marks & Clerk explores how experimental use provides life sciences products with essential relief from patent infringement 15 July 2021